Rising rates of colorectal cancer, especially among young people, have researchers seeking to identify ways to increase cancer screening. Three new studies published in JAMA Network and JAMA Oncology ...

Path-IO is a machine learning platform that incorporates pathology data to predict how patients with non-small cell lung cancer will respond to immunotherapy. Unlike molecular approaches, Path-IO uses ...

FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), showed early signs of clinical benefit in patie ...

Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral lesions significantly reduced lesion size and risk of cancer progression, sparing most patients from ...

Carranza, a child development professional who grew up swinging through trees and swimming in rivers in El Salvador, said she feels at home in the forest at the outdoor preschool she co-founded. She ...

Researchers previously established that exercise may reverse some of the cognitive symptoms associated with “ chemo brain,” which may arise from cancer and treatment and include deficits in memory, ...

The researchers found that for men with low PSA levels prior to radiotherapy, adding hormone therapy, whether short-term or long-term, did not improve overall survival. Men with higher PSA levels ...

When we set about to enhance SEER, we worked with and sought feedback from many groups and experts. This outreach allowed us to better understand the cancer research community’s needs and the ...

A new study highlights the scale and scope of the Trump administration’s termination of National Cancer Institute (NCI) research grants since it slashed cancer research funding in early 2025 and cut ...

Social media was abuzz this week over an article in The Australian about a tech entrepreneur who used artificial intelligence to create a customized vaccine to cure his dog’s cancer. Many commenters ...

Galleri, a blood test that aims to detect over 50 cancers, illustrates the promise and popularity of an emerging technology to screen for cancer. Although the blood test is not approved by the Food ...

Drugs like Wegovy and Zepbound were associated with a 17% lower risk of cancer overall for people with obesity, with greater reductions for specific malignancies.